MiRNA-based therapy for cancer: Tumor suppressor MiRNA-135 suppresses the expression of oncogenic miR-222 in a cell context dependent manner via down regulation of its target gene, 22/July/2014, 5.45 am

MiRNA-based therapy for cancer: Tumor suppressor MiRNA-135 suppresses the expression of oncogenic miR-222 in a cell context dependent manner via down regulation of its target gene, 22/July/2014, 5.45 am

MiRNA-based therapy for cancer: Tumor suppressor MiRNA-135 suppresses the expression of oncogenic miR-222 in a cell context dependent manner via down regulation of its target gene, 22/July/2014, 5.45 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, MiRNA-based therapy for cancer: Tumor suppressor MiRNA-135 suppresses the expression of oncogenic miR-222 in a cell context dependent manner via down regulation of its target gene, 22/July/2014, 5.45 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org